Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Psilocybin by Tryptamine Therapeutics for Fibromyalgia (Fibromyalgia Syndrome): Likelihood of Approval
Psilocybin is under clinical development by Tryptamine Therapeutics and currently in Phase II for Fibromyalgia (Fibromyalgia Syndrome). According to GlobalData,...
Data Insights
Psilocybin by Tryptamine Therapeutics for Irritable Bowel Syndrome: Likelihood of Approval
Psilocybin is under clinical development by Tryptamine Therapeutics and currently in Phase II for Irritable Bowel Syndrome. According to GlobalData,...